Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Birch pollen major allergen Bet v 1 is the major allergen found in birch pollen (*Betula verrucosa*), responsible for triggering allergic reactions in a significant proportion of individuals with birch pollen allergy. It is the prototypical member of the pathogenesis-related protein class 10 (PR-10) family. Its structure includes a hydrophobic cavity capable of binding various ligands, and surface-exposed regions responsible for cross-reactivity with homologous allergens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Birch pollen major allergen Bet v 1 (Bet v 1).